Profil
Douglas Maffei is currently the Vice President-Investor Relations at Seagen Inc. He previously worked as a Senior Director-Investor Relations at Gilead Sciences, Inc.
Aktive Positionen von Douglas Maffei
| Unternehmen | Position | Beginn |
|---|---|---|
| SEAGEN INC. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Douglas Maffei
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
